| Amyris is an industrial biotechnology company that is applies its technology platform to engineer, manufacture and sell products into the Health and Wellness, Clean Skincare, and Flavors and Fragrances markets. Co.'s technology platform allows Co. to engineer microbes and to metabolize renewable, plant-sourced sugars into ingredients. Co. has focused its development activities primarily on the production of Biofene®, its brand of renewable farnesene, a branched hydrocarbon molecule that manufactures through fermentation using engineered microbes. Co.'s farnesene derivatives are sold in various products including nutraceuticals, skin care, fragrances, solvents, and lubricants ingredients. We show 8 historical shares outstanding datapoints in our coverage of AMRS's shares outstanding history.|
Understanding the changing numbers of AMRS shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like AMRS versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching AMRS by allowing them to research AMRS shares outstanding history
as well as any other stock in our coverage universe.